Indication

Arrhythmogenic Left Ventricular Cardiomyopathy

1 clinical trial

1 product

Product
IC14
Clinical trial
Phase 1b Study of IC14 in Arrhythmogenic Cardiomyopathy
Status: Recruiting, Estimated PCD: 2025-02-01